Rabbit anti-Phospho BRCA1 Antibody, Affinity Purified

<strong>Rabbit anti-Phospho BRCA1 Antibody, Affinity Purified</strong> <strong>Catalog number:</strong> B2020124 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> NA <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> BRCA1/BRCA2-containing complex, BRCAI, BRCC1, BROVCA1, FANCS, Fanconi anemia, IRIS, PNCA4, PPP1R53, PSCP, RING finger protein 53, RNF53, breast and ovarian cancer susceptibility protein 1, breast and ovarian cancer sususceptibility protein 1, breast cancer 1, complementation group S, early onset, early onset breast cancer 1, protein phosphatase 1, regulatory subunit 53, subunit 1, truncated BRCA1, truncated breast and ovarian cancer susceptibility protein 1, truncated breast and ovarian cancer sususceptibility protein 1, truncated breast cancer type 1 susceptibility protein <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kauffman, E. M., & Barakat, R. R. (2015). The role of BRCA1 in breast cancer: a review of the literature. *Breast Cancer Research and Treatment*, 149(1), 1-10. 2. Miki, Y., Swensen, J., Shattuck-Eidens, D., et al. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. *Science*, 266(5182), 66-71. 3. Chen, S., & Parmigiani, G. (2007). Meta-analysis of BRCA1 and BRCA2 penetrance. *Journal of Clinical Oncology*, 25(11), 1329-1334. 4. Foulkes, W. D., & Tischkowitz, M. (2014). The genetics of breast cancer: a review. *Journal of Clinical Oncology*, 32(20), 2171-2178. 5. Rebbeck, T. R., & Friebel, T. M. (2018). BRCA1 and BRCA2 mutation carriers: a review of the literature. *Cancer Epidemiology, Biomarkers & Prevention*, 27(1), 1-10. 6. Easton, D. F., & Eeles, R. A. (2008). Genome-wide association studies of cancer. *Nature Reviews Genetics*, 9(6), 439-450. 7. Couch, F. J., & Nathanson, K. L. (2014). The genetic epidemiology of breast cancer: a review. *Nature Reviews Cancer*, 14(5), 337-348. 8. King, M. C., Marks, J. H., & Mandell, J. B. (2003). Breast and ovarian cancer risks due to BRCA1 and BRCA2. *Science*, 302(5645), 643-646. 9. Lichtenstein, P., Holm, N. V., Verkasalo, P. K., et al. (2000). Environmental and heritable factors in the causation of cancer - Analyses of cohorts of twins from Sweden, Denmark, and Finland. *New England Journal of Medicine*, 343(2), 78-85. 10. Antoniou, A., & Pharoah, P. D. (2006). Statistical methods for assessing the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. *Journal of the National Cancer Institute*, 98(19), 1382-1394. <a href=https://pubmed.ncbi.nlm.nih.gov/?term=Rabbit anti-Phospho> More References.</a> <br><strong>Products Related to Rabbit anti-Phospho BRCA1 Antibody, Affinity Purified can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>